Children's health and its association with indoor environments in Danish homes and daycare centres - methods

The principle objective of the Danish research program 'Indoor Environment and Children's Health' (IECH) was to explore associations between various exposures that children experience in their indoor environments (specifically their homes and daycare centers) and their well-being and health. The targeted health endpoints were allergy, asthma, and certain respiratory symptoms. The study was designed with two stages. In the first stage, a questionnaire survey was distributed to more than 17,000 families with children between the ages of 1 and 5. The questionnaire focused on the children's health and the environments within the homes they inhabited and daycare facilities they attended. More than 11,000 questionnaires were returned. In the second stage, a subsample of 500 children was selected for more detailed studies, including an extensive set of measurements in their homes and daycare centers and a clinical examination; all clinical examinations were carried out by the same physician. In this study, the methods used for data collection within the IECH research program are presented and discussed. Furthermore, initial findings are presented regarding descriptors of the study population and selected characteristics of the children's dwellings and daycare centers.

PRACTICAL IMPLICATIONS

This study outlines methods that might be followed by future investigators conducting large-scale field studies of potential connections between various indoor environmental factors and selected health endpoints. Of particular note are (i) the two-stage design - a broad questionnaire-based survey followed by a more intensive set of measurements among a subset of participants who have been selected based on their responses to the questionnaire; (ii) the case-base approach utilized in the stage 2 in contrast to the more commonly used case-control approach; (iii) the inclusion of the children's daycare environment when conducting intensive sampling to more fully capture the children's total indoor exposure; and (iv) all clinical examinations conducted by the same physician. We recognize that future investigators are unlikely to fully duplicate the methods outlined in this study, but we hope that it provides a useful starting point in terms of factors that might be considered when designing such a study.

Systematische Analyse der Geometrie eines definierten Kontrastmittelbolus - Implikationen für die kontrastmittelverstärkte 3D-MR-Angiographie thorakaler Gefäße

PURPOSE

Little is known about the dispersion of a defined contrast bolus during its passage through the heart and pulmonary vasculature. The purpose of this study was to analyze factors influencing a defined contrast bolus for ce-MRA of thoracic vessels.

MATERIALS AND METHODS

For analysis of bolus geometry, an ECG-gated saturation-recovery Turbo-Flash sequence with a TI of 20 msec was used. It was acquired axially at the level of the pulmonary trunc, so that with one data acquisition a curve analysis was possible in the ascending and descending aorta, and in the pulmonary trunc. Twenty-nine patients received 3 ml of Gd-DTPA diluted with saline to a total of 20 ml. Contrast injection was done using a MR compatible power injector with injection rates varying between 1, 2 and 4 ml/sec. Each injection was followed by a saline flush of 20 ml with the same injection rate and mode. Cardiac function was assessed by cine imaging, and phase contrast measurements. After normalization to baseline signal intensity (SI), bolus curves were fitted using a gamma-variate fit and peak signal intensity (peak SI), time-to-peak (TP), upslope, mean transit time (MTT) and dispersion of the contrast bolus were calculated. Furthermore, T (1) and [Gd] in the experimental setting were calculated as follows: T (1) = T (1 o)/ ln [SI/SI (0)], and [Gd] (exp) = [1/T (1) - 1/T (1 o)]/ R (1.) They were then extrapolated [Gd] to clinical conditions by [Gd] (clin) = [Gd] (exp) . 10/1.5, and minimal blood T (1) by T (1)(clin) = 1 / [1/T (1 o) + R (1) [Gd] (clin)].

RESULTS

With increasing injection rate, there was a significant decrease (p < 0.001) of MTT in all target vessels. However, this decrease was not linear: a 4-fold increase in injection rate lead to a 2-fold decrease in MTT e. g. in the ascending aorta. MTT was significantly shorter in the pulmonary trunc compared with that in the ascending and descending aorta (p < 0.001), regardless of injection rate (p < 0.001). Vice versa, dispersion of the contrast bolus was significantly lower in the pulmonary trunc, and increased with higher injection rates. There was no clinically relevant difference in minimal blood T (1) between the different target vessels, for clinical conditions extrapolated values ranged between 20 und 79 msec. Heart function parameters only had a minor influence of bolus curve parameters.

CONCLUSION

Analysis of bolus geometry enables determination of transit times of a defined contrast bolus through a defined target vessel in the thoracic cavity. Bolus geometry is mainly determined by injection parameters, cardiac function is of minor importance. Dispersion of contrast bolus and MTT increase from the pulmonary trunc to the ascending aorta. The knowledge of these facts may help optimizing of injection parameters and the total amount of contrast agent for contrast-enhanced MRA of thoracic vessels.